You searched for "blind"

4681 results found

Considerations in the management of retinal disorders

Vision research presentations and publications explore practice considerations in the management of AMD and diabetic retinopathy. Over the past two decades in Europe there has been a decreasing prevalence of age-related macular degeneration (AMD) and an improvement in visual acuity...

OBITUARY: James Finbarr (Barry) Cullen

On the sad passing of Eye News’ first editor and long-term contributor JF (Barry) Cullen, his friend Hector Chawla takes a look at the life and career of this effervescent character and giant of the ophthalmology world. Barry Cullen was...

An update on inherited retinal disorders (part 1) – overview and assessment of inherited retinal disease

Part 2 of this topic can be found here Inherited Retinal Disease (IRD) is the leading cause of blindness certification in the working age population (age 16-64 years) in England and Wales and the second most common in childhood [1]....

Paediatric ophthalmology training in Malawi through the Vision 2020 LINKS Programme: a decade of partnership

Blinding eye disease in children can lead to a lifetime of dependence and non-productivity for the person afflicted. Sometimes a relatively simple condition such as a refractive error can lead to irreversible disability that could, if caught in time, have...

Millions of patients benefitting from improved care as new NHS IT software rolled out

Innovative IT software designed to tackle waiting lists and reduce discharge delays has been rolled out across more than two thirds of the NHS. The NHS Federated Data Platform securely brings together data currently held in separate systems, making it...

The ABC tragedies: Part one

“In the midst of tragedy, we start the comedy” – Agatha Christie, The ABC Murders. Throughout a career in medicine, we are often faced with tragedy. One of the coping mechanisms is to use humour to navigate the mini everyday...

The use of adalimumab for relapse in patients with Vogt-Koyanagi-Harada disease

In this retrospective, multi-centre, cohort study, the efficacy and safety of Adalimumab (ADA) treatment for the exacerbation or recurrence of Vogt-Koyanagi-Harada (VKH) patients was assessed by investigating the medical records of patients who had received ADA treatment for more than...

Corporate M&A pace gathers momentum

Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

Treatment of diabetic macular oedema

Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...

CHEC ‘Re:Sets’ sights on patient outcomes and growth ambitions

CHEC, one of the largest providers of community-based ophthalmology services in the UK, has launched an enhanced go-to-market strategy that will better align its service offerings and provision with the NHS’ evolving needs.

Planes, trams, and auditoriums: Beware predatory conferencing

Predatory open-access journals and predatory conferences are considered the two main areas of predatory infiltration in academic medicine that are of growing concern [1–7]. Unsolicited publishing requests from potentially predatory publishers occur frequently among faculty in ophthalmology [8]. Predatory conferencing...

Ophthalmology in a War Zone: an interview with Dr Volodymyr Melnyk

It is now nine months since the full-scale Russian invasion of Ukraine commenced in late February 2022, with Putin announcing a “special military operation” to “denazify and demilitarise” Ukraine. The rest of the world, however, saw it for what it...